Jorge Spinolo is an Oncology physician. OpenAlex indexes 27 publications with 1,028 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1045 Southcrest Dr Ste 200
Stockbridge, GA 302816113
Telephone
678-289-0549Provider last certified this registry record 1 Dec 2020.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- SERVIER PHARMACEUTICALS LLCProgram year20251 payment
- ABBVIE INC.Program year20251 payment
- PFIZER INC.Program year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
38.7%Kinase inhibitor14.3%Inlyta100%Part D<11 patientsAromatase Inhibitor14.3%Letrozole100%Part D<11 patients+ 1 more class in this area
Dermatology
16%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor16%Acyclovir100%Part D<11 patientsHormonal (systemic)
13.4%l-Thyroxine13.4%Levothyroxine Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Phase I trial of an antisense oligonucleotide OL(1)p53 in hematologic malignancies.
Journal of Clinical Oncology
1996 - Allogeneic bone marrow transplantation for leukemia following piperazinedione and fractionated total body irradiation
American Journal of Hematology
1994 - Cisplatin-CBV with Autologous Bone Marrow Transplantation for Relapsed Hodgkin's Disease
Leukemia & lymphoma/Leukemia and lymphoma
1993
Similar KOLs
Other experts from the same institution or the same specialty.
Freddie Bray
Centre National de la Recherche Scientifique
Jacques Ferlay
Centre international de recherche sur le cancer
Hermann Brenner
German Cancer Research Center
Isabelle Soerjomataram
Centre international de recherche sur le cancer
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”